Short-Term Outcomes of Percutaneous Trephination with a Platelet Rich Plasma Intrameniscal Injection for the Repair of Degenerative Meniscal Lesions. A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study
In brief
This double-blind, placebo-controlled randomised trial examined chronic degenerative meniscal tears treated with needle trephination, with or without platelet-rich plasma (PRP) injected into the meniscus. The authors report fewer healing failures and fewer later arthroscopies when PRP was added, along with more patients reaching meaningful symptom improvement.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Short-Term Outcomes of Percutaneous Trephination with a Platelet Rich Plasma Intrameniscal Injection for the Repair of Degenerative Meniscal Lesions. A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Authors: Rafal Kaminski, Marta Maksymowicz-Wleklik, Krzysztof Kulinski, Katarzyna Kozar- Kaminska, Agnieszka Dabrowska-Thing, Stanislaw Pomianowski Link: https://www.ncbi.nlm.nih.gov/pubmed/30781461 Year of Publication: 2019
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

